Author

J. M. Fernandes Neto

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Assay:proteomics· 1

Frequent Co-Authors

R. Bernards· 2 shared A. Jurgens· 1 shared A. Martinez-Marti· 1 shared A. Villanueva· 1 shared B. Evers· 1 shared B. Morris· 1 shared C. Lieftink· 1 shared C. McLean· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

R. Bernards

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintAug 17, 2023

A fluorescence-based sensor screen identifies MED12 as a potential microsatellite instability regulator in colon cancer

J. M. Fernandes Neto, S. Venkatesan, M. Dias…·R. Bernards

DOI 10.1101/2023.08.17.553681

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivOct 29, 2019

Multiple Low Dose therapy: an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours

J. M. Fernandes Neto, E. Nadal, S. N. Ooft…·R. Bernards

This paper shows that using multiple low doses of drugs targeting different components of a signaling pathway can effectively treat EGFR inhibitor-resistant NSCLC without resistance development.

DOI 10.1038/s41467-020-16952-9

humanexperimental assay

𝕏 PostBluesky